For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
In the latest session, Repare Therapeutics Inc (NASDAQ: RPTX) closed at $1.15 down -5.74% from its previous closing price of $1.22. In other words, the price has decreased by -$5.74 from its previous closing price. On the day, 0.57 million shares were traded. RPTX stock price reached its highest trading level at $1.2048 during the session, while it also had its lowest trading level at $1.115.
Ratios:
For a deeper understanding of Repare Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.45 and its Current Ratio is at 6.45. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Stifel on June 09, 2023, Upgraded its rating to Buy and sets its target price to $16 from $11 previously.
On February 03, 2023, Morgan Stanley Downgraded its rating to Equal-Weight which previously was Overweight and also lowered its target price recommendation from $28 to $15.
On January 06, 2023, CapitalOne started tracking the stock assigning a Overweight rating and target price of $28.CapitalOne initiated its Overweight rating on January 06, 2023, with a $28 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 28 ’24 when Segal Lloyd Mitchell sold 2,650 shares for $4.62 per share. The transaction valued at 12,243 led to the insider holds 110,049 shares of the business.
Segal Lloyd Mitchell sold 2,491 shares of RPTX for $11,533 on Apr 01 ’24. The PRESIDENT AND CEO now owns 107,558 shares after completing the transaction at $4.63 per share. On Mar 28 ’24, another insider, Forte Steve, who serves as the EVP, CHIEF FINANCIAL OFFICER of the company, sold 825 shares for $4.62 each. As a result, the insider received 3,812 and left with 45,564 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RPTX now has a Market Capitalization of 48887304 and an Enterprise Value of -125005936. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.73 while its Price-to-Book (P/B) ratio in mrq is 0.28. Its current Enterprise Value per Revenue stands at -1.879 whereas that against EBITDA is 1.385.
Stock Price History:
The Beta on a monthly basis for RPTX is 0.86, which has changed by -0.8099688 over the last 52 weeks, in comparison to a change of 0.23883796 over the same period for the S&P500. Over the past 52 weeks, RPTX has reached a high of $8.49, while it has fallen to a 52-week low of $1.15. The 50-Day Moving Average of the stock is -46.06%, while the 200-Day Moving Average is calculated to be -62.76%.
Shares Statistics:
For the past three months, RPTX has traded an average of 433.97K shares per day and 413170 over the past ten days. A total of 42.51M shares are outstanding, with a floating share count of 30.52M. Insiders hold about 28.20% of the company’s shares, while institutions hold 45.04% stake in the company. Shares short for RPTX as of 1735603200 were 1303624 with a Short Ratio of 3.00, compared to 1732838400 on 576525. Therefore, it implies a Short% of Shares Outstanding of 1303624 and a Short% of Float of 5.07.
